Home Company The team Obesity Jobs About

COMPANY   Presentation   A new approach   Our targets   Development   ObeTherapy's slide show   THE TEAM   The core team   Advisors   The scientific advisory board   OBESITY   What is obesity?   Obesity costs   Obesity market   JOBS   Job opportunities   Send your CV   ABOUT   Genopole®   Info/Press   Collaborations   Credits   contact us	COMPANY > DEVELOPMENT          ObeTherapy's goal is to become a worldwide leader in the discovery and development of efficient drugs for treating or preventing, obesity, type II diabetes and hyperlipidemia. ObeTherapy's leadership in the field is the result of a unique and innovative approach that permits the identification of reliable, tissue specific, and non redundant targets based on the genetics of the lean phenotype in human. ObeTherapy has developed and patented new in-vitro and cell culture assays on its first target. The company is engaged in an active research effort to evaluate the compounds identified through these assays and to advance our best candidates to the preclinical stage early 2009.       ObeTherapy's Presentation PC MAC
	top of page

home . Contact us . Access . Sitemap . Terms of use .

© All Right Reserved. ® OBETHERAPY v2.0 2005. Last update: 2.6.2009

Designed by ® ATRAGENE Web Manager 2.0